This inpatient and outpatient Clinical Research Center has as its principal purposes 1) to facilitate the transfer of basic knowledge generated in our research laboratories to the clinical arena, in respect both to the elucidation of pathogenetic mechanisms and to the better care of patients, and 2) to augment collaborations between our clinicians and researchers. Twenty-two research projects are proposed. Among these are studies in human bone marrow transplantation, including treatment of graft versus host disease, assessment of systems currently used for histocompatibility typing in respect to bone marrow transplantation, the source of complicating cytomegalovirus infection, and other questions in the biology of marrow replacement. The immunologic factors associated with the evolution of hepatitis B virus infection from acute hepatitis to chronic active hepatitis will be the subject of another study. The contribution of Hageman factor-kininogen and complement systems to progressive interstitial lung disease, bronchial asthma, iodide sensitivity and other inflammatory disorders will be tested. The usefulness of thoracic duct drainage in conjunction with immunosuppressive drugs in reversing the autoimmunity of rheumatoid arthritis will be studied. Red cell ghosts will be used to deliver specific therapeutic agents in Gaucher's disease and iron overload syndromes. The behavior of a family of human growth hormones will be studied in relation to various pituitary release stimuli. Other investigations include studies on cholesterol, lipoprotein, and weight loss, activation of the terminal components of human complement in autoimmune diseases and oxygenation in hypoxic chronic obstructive pulmonary disease.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000833-16
Application #
3090129
Study Section
General Clinical Research Centers Committee (CLR)
Project Start
1977-12-01
Project End
1990-11-30
Budget Start
1989-12-01
Budget End
1990-11-30
Support Year
16
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Winn, Virginia D; Gormley, Matthew; Fisher, Susan J (2011) The Impact of Preeclampsia on Gene Expression at the Maternal-Fetal Interface. Pregnancy Hypertens 1:100-8
Delaney, Joseph A C; Scherzer, Rebecca; Biggs, Mary L et al. (2010) Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima-media thickness. AIDS 24:2201-9
Pan, Warren W; Li, Jain-Dong; Huang, Shuang et al. (2010) Synergistic activation of NF-{kappa}B by bacterial chemoattractant and TNF{alpha} is mediated by p38 MAPK-dependent RelA acetylation. J Biol Chem 285:34348-54
Huang, XueSong; Chen, Ling-Yu; Doerner, Astrid M et al. (2009) An atypical protein kinase C (PKC zeta) plays a critical role in lipopolysaccharide-activated NF-kappa B in human peripheral blood monocytes and macrophages. J Immunol 182:5810-5
Mukherjee, Sumanta; Chen, Ling-Yu; Papadimos, Thomas J et al. (2009) Lipopolysaccharide-driven Th2 cytokine production in macrophages is regulated by both MyD88 and TRAM. J Biol Chem 284:29391-8
Chen, Ling-Yu; Pan, Zhixing K (2009) Synergistic activation of leukocytes by bacterial chemoattractants: potential drug targets. Endocr Metab Immune Disord Drug Targets 9:361-70
Chen, Ling-Yu; Pan, Warren W; Chen, Miao et al. (2009) Synergistic induction of inflammation by bacterial products lipopolysaccharide and fMLP: an important microbial pathogenic mechanism. J Immunol 182:2518-24
Ito, Tatsuo; Yadav, Neelu; Lee, Jaeho et al. (2009) Arginine methyltransferase CARM1/PRMT4 regulates endochondral ossification. BMC Dev Biol 9:47
Price, Richard W; Parham, Robin; Kroll, Jing Lu et al. (2008) Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in defining CSF HIV-1 origin. Antivir Ther 13:369-74
Dawson, Arthur; Abel, Susan L; Loving, Richard T et al. (2008) CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J Clin Sleep Med 4:538-42

Showing the most recent 10 out of 871 publications